Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL155621 | 0.98 | ALDH1A1 (0.32) | ALDH1A1L3MBTL1HSPD1BLMHSPE1 | |
| SCHEMBL27618765 | 0.96 | ALDH1A1 (0.31) | ALDH1A1L3MBTL1HSPD1BLMHSPE1 | |
| SCHEMBL5013321 | 0.96 | ALDH1A1 (0.31) | ALDH1A1L3MBTL1HSPD1BLMHSPE1 | |
| SCHEMBL9242224 | 0.90 | MMP2 (0.35) | L3MBTL1 | |
| SCHEMBL26134786 | 0.80 | — | — | |
| Potassium Ion SCHEMBL26134783 | 0.78 | — | — | |
| SCHEMBL5611380 | 0.78 | HSPD1 (0.42) | ALDH1A1HSPD1BLMHSPE1 | |
| Ammonia Solution, Strong SCHEMBL27832592 | 0.76 | HSPD1 (0.41) | HSPD1BLMHSPE1 | |
| SCHEMBL28351733 | 0.75 | CHRM1 (0.35) | HSPD1BLMHSPE1 | |
| SCHEMBL9683076 | 0.74 | HSD11B1 (0.40) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12472144-B2 | Pharmaceutical composition comprising eliglustat | AMNEAL PHARMACEUTICALS LLC (US) | 2025-11-18 | — | — | US | claimed |
| US-20250332144-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ELIGLUSTAT | AMNEAL PHARMACEUTICALS LLC (US) | 2025-10-30 | — | — | US | claimed |
| US-12440472-B2 | Stable tryptamine oral films | INTELGENX CORP. (CA) | 2025-10-14 | — | — | US | claimed |
| EP-3346998-B1 | TOPICAL FILM DELIVERY SYSTEM | SIDMAK LABORATORIES INDIA PVT LTD (IN) | 2025-04-16 | — | — | EP | claimed |
| US-20250057783-A1 | ORAL FILMS OF ANTIPRURITIC DRUGS | LAURUS LABS LTD (IN) | 2025-02-20 | — | — | US | claimed |
| EP-4456873-A1 | ORAL FILMS OF ANTIPRURITIC DRUGS | Laurus Labs Limited (IN) | 2024-11-06 | — | — | EP | claimed |
| US-12029722-B2 | Dosage delivery film | Spartak LLC (US) | 2024-07-09 | — | — | US | claimed |
| US-20240189299-A1 | ORAL FILM OF CFTR MODULATOR(S) | LAURUS LABS LIMITED (IN) | 2024-06-13 | — | — | US | claimed |
| EP-4304593-A1 | ORAL FILM OF CFTR MODULATOR(S) | Laurus Labs Limited (IN) | 2024-01-17 | — | — | EP | claimed |
| US-20230270716-A1 | GLYCOPYRROLATE ORAL FILM AND IT'S PROCESS | SUVEN PHARMACEUTICALS LIMITED (IN) | 2023-08-31 | — | — | US | claimed |
| WO-1994017132-A9 | ALGAL PLASTICS | — | 1994-09-15 | — | — | WO | claimed |
| WO-1994017132-A1 | ALGAL PLASTICS | INTERNATIONAL TECHNOLOGY MANAGEMENT ASSOCIATES, LTD (US) | 1994-08-04 | — | — | WO | claimed |
| WO-1993020140-A1 | BIODEGRADABLE POLYMER COMPOSITIONS | PARKE-DAVIS & COMPANY (US) | 1993-10-14 | — | — | WO | claimed |
| WO-1993020141-A1 | BIODEGRADABLE STARCH DERIVATIVE COMPOSITIONS | PARKE-DAVIS & COMPANY (US) | 1993-10-14 | — | — | WO | claimed |
| EP-0298920-B1 | DESTRUCTURIZED STARCH CONTAINING A FINITE AMOUNT OF ELECTROLYTES AND PROCESS FOR MAKING SAME | WARNER-LAMBERT COMPANY (US) | 1992-12-09 | — | — | EP | claimed |
| US-4900361-A | Destructurized starch essentially containing no bridged phosphate groups and process for making same | WARNER-LAMBERT COMPANY (US) | 1990-02-13 | — | — | US | claimed |
| EP-0326517-A1 | Method of producing destructurized starch | WARNER-LAMBERT COMPANY (US) | 1989-08-02 | — | — | EP | claimed |
| EP-0304401-A2 | Shaped articles made from pre-processed starch | WARNER-LAMBERT COMPANY (US) | 1989-02-22 | — | — | EP | claimed |
| EP-0298920-A2 | Destructurized starch containing a finite amount of electrolytes and process for making same | WARNER-LAMBERT COMPANY (US) | 1989-01-11 | — | — | EP | claimed |
| US-4268613-A | Agent for protecting the surface of lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1981-05-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12472144-B2 | Pharmaceutical composition comprising eliglustat | GBA1, GBA2, GALC | ALDH1A1 1931/4885L3MBTL1 1809/4885HSPD1 4429/4885 |
| US-12440472-B2 | Stable tryptamine oral films | TPH1, TPH2, TPSB2 | ALDH1A1 3942/4885L3MBTL1 4488/4885HSPD1 4619/4885 |
| US-20230270716-A1 | GLYCOPYRROLATE ORAL FILM AND IT'S PROCESS | PGA5, GYPA, GALR3 | ALDH1A1 4479/4885L3MBTL1 4883/4885HSPD1 4787/4885 |
| US-20250332144-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ELIGLUSTAT | GBA1, GBA2, GALC | ALDH1A1 1931/4885L3MBTL1 1809/4885HSPD1 4429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.